1Christopher B.A viewpoint of Ziprasidone[J].CNS Drugs,1997,8(2):162.
2Seeger TF,Seymour PA,Schmidt AW,et al.Ziprasidone (CP-88059):a new antipsychotic with combined dopamine and serotonin recepter antagonist activity[J].J Pharmacol Exp Ther,1995,275(1):101-113.
3Prakash C,Kamel A,Cui D,et al.Ziprasidone metabolism and cytochrome P450 isoform[poster].San Doego:Annual Meeting of the American Psychiatric Association,1997.
4Wilner KD,Hansen RA,Folger CJ,et al.Effects of cimetidine or Maalox on ziprasidone pharmacokinetics (poster).San Digego:Annual Meeting of the American Psychiatric Association,1997.
5Tensfeldt TG,Wilner KD,Baris B,et al.Steady-state pharmacokinetics of ziprasidone in healthy elderly and young volunteers[abstract].San Diego:Annual Meeting of the American Psychiatric Association,1997.
6Tandon R,Harrigan E.Ziprasidone:a novel antipsychotic with unique pharmacology and therapeutic potentiaI.J Set Res,In press.
3Vacheron-Trystram MN, Braitman A, Cheref S, et al. Antipsychotics in bipolar disorders[J]. Encephale, 2004, 30(5):417-424.
4Geoffroy PA, Etain B, Henry C, et al. Combination therapy formanic phases: a critical review of a common practice[J]. CNSNeurosci Ther, 2012,18(12):957-964.
5Sacchetti E, Galluzzo A, Valsecchi P. Oral ziprasidone in thetreatment of patients with bipolar disorders: a critical review[J].Expert Rev Clin Pharmacol, 2011, 4(2):163-179.
6Nguyen LN, Guthrie SK. Risperidone treatment of bipolar mania[J]. Ann Pharmacother, 2006, 40(4):674-682.
7Warrington L, Lombardo I, Loebel A, et al. Ziprasidone for thetreatment of acute manic or mixed episodes associated withbipolardisorder[J]. CNS Drugs, 2007, 21(10):835-849.
8Rendell JM, Gijsman HJ, Bauer MS, et al. Risperidone alone orin combination for acute mania[J]. Cochrane Database Syst Rev,2006, 25(1):CD004043.
